SuperworthDNA X EPS SONM
Diluted earnings per share by quarter and over the last twelve months, from 2018.
- Last 12 months, to Jun 30, 2026
- −$9.27
- Latest quarter, Q2 FY26
- −$0.92
- Fiscal year 2025
- −$26.10
DNA X's earnings per share was −$9.27 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.92.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$26.10 | n/a |
| FY2024 | −$125.85 | −35058% |
| FY2023 | $0.36 | n/a |
| FY2022 | −$120.60 | n/a |
| FY2021 | −$799.20 | n/a |
| FY2020 | −$1611.00 | n/a |
| FY2019 | −$2466.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.92 | n/a | −$9.27 | |
| Q1 FY26 | $5.01 | +255% | −$22.50 | |
| Q4 FY25 | −$8.53 | n/a | −$26.10 | |
| Q3 FY25 | −$4.83 | n/a | −$97.02 | |
| Q2 FY25 | −$14.15 | n/a | −$101.51 | |
| Q1 FY25 | $1.41 | n/a | −$112.74 | |
| Q4 FY24 | −$79.45 | n/a | −$125.85 | |
| Q3 FY24 | −$9.32 | −531% | −$51.98 | |
| Q2 FY24 | −$25.38 | −1382% | −$40.50 | |
| Q1 FY24 | −$11.70 | −750% | −$13.14 | |
| Q4 FY23 | −$5.58 | n/a | $0.36 | |
| Q3 FY23 | $2.16 | n/a | $0.54 |
Against its peers
Companies in Technology nearest DNA X's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| SONMDNA X | −$9.27 | |
| MSGMMotorsport Games | $0.43 | +187% a year |
| FIEEFiEE | $0.34 | |
| NSYSNortech Systems | $0.37 | |
| Peer median | $0.37 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on DNA X
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.